Crinetics Pharmaceuticals CRNX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's change in lease liabilities?
- Crinetics Pharmaceuticals (CRNX) reported change in lease liabilities of -$685K in Q1 2026.
- How has Crinetics Pharmaceuticals's change in lease liabilities changed year-over-year?
- Crinetics Pharmaceuticals's change in lease liabilities increased by 24.1% year-over-year, from -$903K to -$685K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.